LifeScience
Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic a...
October 24, 2022 | News
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ DynaCellect™ Magnetic Separation ...
October 21, 2022 | News
Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...
October 13, 2022 | News
“Big 3” expected to generate around 80% of sales growth and > 50% of total sales in 2025 Strategic and targeted investments for annu...
October 11, 2022 | News
An Immunity research study has found that the previously identified disease associated microglia (DAM) population detected in murine Alzheimer’s dise...
October 11, 2022 | News
Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...
September 28, 2022 | News
NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...
September 27, 2022 | News
JB Pharma is sitting pretty, ranked at a healthy 23 among the Indian Pharmaceutical players and underlining its meteoric rise with an outstanding growth ra...
September 22, 2022 | News
ClavystBio, a company established by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek, today announced its launch to accelerate the commercia...
September 15, 2022 | News
BioChallenge facilitates access to Cytiva's services and expertise to scale up efficiently, mitigate risks and reduce time to go to market Application p...
September 12, 2022 | News
Increases manufacturing capacity for the Mobius® single-use portfolio Creates more than 800 jobs by the end of 2028 Investment further strengt...
September 12, 2022 | News
Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...
September 02, 2022 | News
This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...
September 01, 2022 | News
Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...
August 29, 2022 | News
Most Read
Bio Jobs
News
Editor Picks